HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Abstract
Pseudomonas aeruginosa galactose- and fucose-binding lectins (PA-IL and PA-IIL) contribute to the virulence of this pathogenic bacterium, which is a major cause of morbidity and mortality in cystic fibrosis patients. The crystal structure of PA-IIL in complex with fucose reveals a tetrameric structure. Each monomer displays a nine-stranded, antiparallel b-sandwich arrangement and contains two close calcium cations that mediate the binding of fucose in a recognition mode unique among carbohydrate-protein interactions. Experimental binding studies, together with theoretical docking of fucose-containing oligosaccharides, are consistent with the assumption that antigens of the Lewis a (Le(a)) series may be the preferred ligands of this lectin. Precise knowledge of the lectin-binding site should allow a better design of new antibacterial-adhesion prophylactics.
AuthorsEdward Mitchell, Corinne Houles, Dvora Sudakevitz, Michaela Wimmerova, Catherine Gautier, Serge Pérez, Albert M Wu, Nechama Gilboa-Garber, Anne Imberty
JournalNature structural biology (Nat Struct Biol) Vol. 9 Issue 12 Pg. 918-21 (Dec 2002) ISSN: 1072-8368 [Print] United States
PMID12415289 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adhesins, Bacterial
  • Lectins
  • Macromolecular Substances
  • Oligosaccharides
  • adhesin, Pseudomonas
  • Fucose
  • Calcium
Topics
  • Adhesins, Bacterial (chemistry, metabolism)
  • Bacterial Adhesion
  • Binding Sites
  • Calcium (chemistry, metabolism)
  • Crystallography, X-Ray
  • Cystic Fibrosis (microbiology)
  • Fucose (chemistry, metabolism)
  • Humans
  • Lectins (chemistry, metabolism)
  • Lung (microbiology)
  • Macromolecular Substances
  • Models, Molecular
  • Oligosaccharides (chemistry, metabolism)
  • Protein Binding
  • Pseudomonas aeruginosa (pathogenicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: